Sökning: WFRF:(Barosi G.) > A unified definitio...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03305naa a2200529 4500 | |
001 | oai:DiVA.org:uu-24970 | |
003 | SwePub | |
008 | 070208s2007 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-249702 URI |
024 | 7 | a https://doi.org/10.1038/sj.leu.24044732 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Barosi, G.4 aut |
245 | 1 0 | a A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia :b results of a consensus process by an international working group |
264 | c 2006-11-16 | |
264 | 1 | b Springer Science and Business Media LLC,c 2007 |
338 | a print2 rdacarrier | |
520 | a A widely accepted definition of resistance or intolerance to hydroxyurea (HU) in patients with essential thrombocythemia (ET) is lacking. An international working group (WG) was convened to develop a consensus formulation of clinically significant criteria for defining resistance/intolerance to HU in ET. To this aim, an analytic hierarchy process (AHP), a multiple-attribute decision-making technique, was used. The steps consisted of selecting the candidate criteria for defining resistance/intolerance; identifying the motivations that could influence the preference of the WG for any individual criterion; comparing the candidate criteria in a pair-wise manner; and grading them according their ability to fulfill the motivations. Every step in the model was derived by questionnaires or group discussion. The WG proposed that the definition of resistance/intolerance should require the fulfillment of at least one of the following criteria: platelet count greater than 600,000/micro l after 3 months of at least 2 g/day of HU (2.5 g/day in patients with a body weight over 80 kg); platelet count greater than 400,000/micro l and WBC less than 2500/micro l or Hb less than 10 g/dl at any dose of HU; presence of leg ulcers or other unacceptable muco-cutaneous manifestations at any dose of HU; HU-related fever. | |
653 | a essential thrombocythemia | |
653 | a hydroxyurea | |
653 | a analytic hierarchy process | |
653 | a resistance | |
653 | a intolerance | |
653 | a MEDICINE | |
653 | a MEDICIN | |
700 | 1 | a Besses, C.4 aut |
700 | 1 | a Birgegård, Gunnar,d 1944-u Uppsala universitet,Institutionen för medicinska vetenskaper,Hematologi4 aut0 (Swepub:uu)gunnarbg |
700 | 1 | a Briere, J.4 aut |
700 | 1 | a Cervantes, F.4 aut |
700 | 1 | a Finazzi, G.4 aut |
700 | 1 | a Gisslinger, H.4 aut |
700 | 1 | a Griesshammer, M.4 aut |
700 | 1 | a Gugliotta, L.4 aut |
700 | 1 | a Harrison, C.4 aut |
700 | 1 | a Hasselbalch, H.4 aut |
700 | 1 | a Lengfelder, E.4 aut |
700 | 1 | a Reilly, J. T.4 aut |
700 | 1 | a Michiels, J. J.4 aut |
700 | 1 | a Barbui, T.4 aut |
710 | 2 | a Uppsala universitetb Institutionen för medicinska vetenskaper4 org |
773 | 0 | t Leukemiad : Springer Science and Business Media LLCg 21:2, s. 277-280q 21:2<277-280x 0887-6924x 1476-5551 |
856 | 4 | u https://www.nature.com/articles/2404473.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-24970 |
856 | 4 8 | u https://doi.org/10.1038/sj.leu.2404473 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy